Please login to the form below

Not currently logged in
Email:
Password:

Cardax adds big pharma experience to board

Brings in former Novartis, BMS and Boehringer executives

tamar howson cardaxHawaii-based anti-inflammatory specialist Cardax has added three new members to its board, each with experience at a major pharma company.

George Bickerstaff is a former chief financial officer of Novartis who is now managing director at investment bank MM Dillon. He was also chief financial officer at IMS Health.

Tamar Howson (pictured right) is a former senior business development executive at Bristol-Myers Squibb and SmithKline Beecham (now GSK) who now acts as an independent consultant to life sciences companies.

The final new addition is Terence Kelly who provides Cardax with scientific experience having served as VP, department of medicinal chemistry at Boehringer Ingelheim. He is currently president and CEO of CoMentis, a private biotech company focused on neurodegenerative diseases.

“The distinctive, yet complementary skills of our new board members provide a strong foundation as we develop and commercialise our nutraceutical and pharmaceutical programmes,” said David Watumull, president and CEO of Cardax.

These programmes are focused on developing products that are as effective as steroids and NSAIDS but have safer profiles.

19th June 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics